title: Leveraging image cytometry for the development of clinically feasible biomarkers: evaluation of activated caspase-3 in fine needle aspirate biopsies.
abstract: Quantitation of activated caspases in xenograft models by laser scanning cytometry has demonstrated mechanism-specific biological activity of Anti-Trail Receptor immunoglobulin therapies in situ. These preclinical data confirmed that caspase activation is an early event that precedes tumor regression. To apply this platform for clinical monitoring of caspase activation using fine needle aspirate (FNA) biopsies, additional assay feasibility and validation experiments need be addressed. Furthermore, important instrument parameters should be considered including the maintenance and operation of the cytometer in a controlled state to ensure aspects like data traceability, reliability, and integrity. In the present chapter we describe a method to evaluate caspase activation in Colo205 cells and fine needle aspirate tumors by slide-based, laser scanning cytometry. This approach can be applied to cell cultures, preclinical and clinical fine needle aspirate material.
authors.affiliation: Department of Clinical Immunology, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California, USA.
authors.forename: Gloria
authors.initials: G
authors.lastname: Juan
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Zoog
authors.forename: John
authors.initials: J
authors.lastname: Ferbas
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects; D014408:Biomarkers, Tumor / Q000378:metabolism*; D044963:Biopsy, Fine-Needle; D053148:Caspase 3 / Q000378:metabolism*; D045744:Cell Line, Tumor; D015179:Colorectal Neoplasms; D003603:Cytotoxins / Q000494:pharmacology; D004789:Enzyme Activation; D006801:Humans; D047569:Laser Scanning Cytometry / Q000379:methods*; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand / Q000819:agonists; D013194:Staining and Labeling / Q000379:methods
chemical_list: D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; D003603:Cytotoxins; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; C554537:conatumumab; D053148:Caspase 3